Damage did not independently influence mortality in childhood systemic lupus erythematosus

被引:19
作者
Appenzeller, S [1 ]
Marini, R
Costallat, LTL
机构
[1] Univ Estadual Campinas, Fac Internal Med, Dept Internal Med, BR-13081970 Campinas, SP, Brazil
[2] Univ Estadual Campinas, Dept Pediat, BR-13081970 Campinas, SP, Brazil
关键词
childhood-onset SLE; mortality; prognosis factors;
D O I
10.1007/s00296-004-0552-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyze clinical, laboratory and treatment features associated with death in a childhood-onset SLE population. Patients and methods: Patients with childhood-onset SLE followed at the State University of Campinas, Brazil, between 1980 and 2002 were included. Data on clinical and laboratory features of the disease were collected regularly. Logistic regression was used for analyzing association between clinical and laboratory features and death. Kaplan-Meyer tests were used to estimate the survival curves. Results: Of 61 patients identified, six were lost to follow-up during the first year of disease. The mean follow-up period of the remaining 55 patients was 3.25 years (SD=1.2). Mean SLICC/ACR-DI score was 4.9 (SD=3.4). Death occurred in 12 (21.8%) of 55 patients. Direct causes of death were: infection in six (50%), stroke in four (33.3%), and renal insufficiency in two (16.7%). Five patients (41.7%) died during the first 5 years of disease due to infection. Male gender (p=0.004; OR=9.1; 95% CI=7.6-21.0), infection (p=0.001; OR=4.2; 95% CI=1.6-15.2) and nephritis (p=0.02; OR=2.3; 95% CI=1.3-5.2) were independent factors associated with death in the multivariate analysis. The global survival rate adjusted for duration of disease was 93.9% in the first year of disease, 88.9% in the second year, 80.8% in the fifth year and 48.1% in 20 years of follow-up. When comparing survival curves, male gender, the presence of infection during the course of the disease and the presence of nephritis during follow-up had a worse survival. Conclusion: Male gender, the presence of infection and nephritis were independent risk factors for death in our Brazilian cohort. Damage did not independently influence survival in this study.
引用
收藏
页码:619 / 624
页数:6
相关论文
共 36 条
[1]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[2]  
BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
[3]   Risk factors for damage in childhood-onset systemic lupus erythematosus - Cumulative disease activity and medication use predict disease damage [J].
Brunner, HI ;
Silverman, ED ;
To, T ;
Bombardier, C ;
Feldman, BM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (02) :436-444
[4]  
Brunner HI, 1999, ARTHRITIS RHEUM-US, V42, P1354, DOI 10.1002/1529-0131(199907)42:7<1354::AID-ANR8>3.0.CO
[5]  
2-4
[6]   SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND IMMUNOLOGICAL PATTERNS OF DISEASE EXPRESSION IN A COHORT OF 1,000 PATIENTS [J].
CERVERA, R ;
KHAMASHTA, MA ;
FONT, J ;
SEBASTIANI, GD ;
GIL, A ;
LAVILLA, P ;
DOMENECH, I ;
AYDINTUG, AO ;
JEDRYKAGORAL, A ;
DERAMON, E ;
GALEAZZI, M ;
HAGA, HJ ;
MATHIEU, A ;
HOUSSIAU, F ;
INGELMO, M ;
HUGHES, GRV ;
CERVERA, R ;
SEBASTIANI, GD ;
FONT, J ;
KHAMASHTA, MA ;
HUGHES, GRV ;
FONT, J ;
CERVERA, R ;
LOPEZSOTO, A ;
VIVANCOS, J ;
INGELMO, M ;
URBANOMARQUEZ, A ;
KHAMASHTA, MA ;
VIANNA, J ;
HUGHES, GRV ;
GIL, A ;
LAVILLA, P ;
PINTADO, V ;
LOPEZDUPLA, M ;
VAZQUEZ, JJ ;
SEBASTIANI, GD ;
DERAMON, E ;
CAMPS, M ;
FRUTOS, MA ;
PERELLO, I ;
SANTOS, PG ;
ABARCA, M ;
NEBRO, AF ;
DOMENECH, I ;
TOKGOZ, G ;
AYDINTUG, AO ;
JEDRYKAGORAL, A ;
MALDYKOWA, H ;
CHWALINSKASADOWSKA, H ;
GALEAZZI, M .
MEDICINE, 1993, 72 (02) :113-124
[7]   Neurologic, ophthalmic, and neuropsychiatric manifestations of pediatric systemic lupus erythematosus [J].
Chan, DQ .
OPTOMETRY AND VISION SCIENCE, 2000, 77 (08) :388-394
[8]  
COSTALLAT LTL, 1994, CLIN EXP RHEUMATOL, V12, P603
[9]   SYSTEMIC LUPUS-ERYTHEMATOSUS IN 18 BRAZILIAN MALES - CLINICAL AND LABORATORY ANALYSIS [J].
COSTALLAT, LTL ;
COIMBRA, AMV .
CLINICAL RHEUMATOLOGY, 1993, 12 (04) :522-525
[10]  
DUBOIS EL, 1964, JAMA-J AM MED ASSOC, V190, P104